NCT06880861

Brief Summary

This study evaluates relationships among physical activity, thinking, and memory after cancer treatment in survivors of adolescent and young adult cancers.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
4mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Jul 2025Sep 2026

First Submitted

Initial submission to the registry

March 12, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 18, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

1.2 years

First QC Date

March 12, 2025

Last Update Submit

December 9, 2025

Conditions

Keywords

canceradolescentyoung adultcognitionmemoryexercisephysical activity

Outcome Measures

Primary Outcomes (1)

  • Cognitive performance on Stroop task

    Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions.

    Up to 4 weeks

Secondary Outcomes (9)

  • Cognitive performance on Visual Memory Test

    2 weeks

  • Cognitive performance on Verbal Memory Test

    2 weeks

  • Cognitive performance on Symbol Digit Coding Test

    2 weeks

  • Cognitive performance on Shifting Attention Test

    2 weeks

  • Cognitive performance on Continuous Performance Test

    Up to 4 weeks

  • +4 more secondary outcomes

Study Arms (1)

Observational

Patients complete questionnaires and cognitive tasks and wear an activity monitor to measure physical activity on study. Some patients may optionally participate in an interview on study.

Other: Non-Interventional Study

Interventions

Non-Interventional Study

Observational

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with primary diagnosis of cancer when 15-39 years old.

You may qualify if:

  • Adults (aged 18+ years)
  • Primary diagnosis of cancer when 15-39 years-old
  • Access to a desktop computer or laptop with reliable internet access
  • No gross motor impairments that prohibit ambulation
  • Willing to complete study requirements
  • English speaking

You may not qualify if:

  • Diagnosed with nonmelanoma skin cancer only
  • Not diagnosed with cancer in adolescent and young adult (AYA) age range of 15-39 years
  • Scheduled travel during the study period that is not indicative of individual's normal schedule

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Arizona

Scottsdale, Arizona, 85259, United States

RECRUITING

Related Links

MeSH Terms

Conditions

NeoplasmsMotor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Diane K. Ehlers, PhD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Clinical Trials Referral Office

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2025

First Posted

March 18, 2025

Study Start

July 1, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

December 17, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

De-identified, limited datasets will be shared with other researchers upon request or according to journal publication requirements

Shared Documents
STUDY PROTOCOL
Time Frame
At time of first publication (as required by journals) until last manuscript is published.
Access Criteria
If required by journal and case by case upon request to the PI

Locations